20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Fatty acid derivatives for treating non-alcoholic steatohepatitis
#602PREPARED FOODS HAVING HIGH EFFICACY OMEGA-6/OMEGA-3 BALANCED POLYUNSATURATED FATTY ACIDS
#603METHOD FOR MEASURING AND MANAGING RED BLOOD CELL OMEGA-3 FATTY ACID DOCOSAHEXAENOIC ACID LEVEL IN HUMAN FEMALES TO SUPPORT A TERM PREGNANCY AND REDUCE RISK OF SPONTANEOUS PRETERM BIRTH
#604Alpha polyglutamated methotrexate and uses thereof
#605COMPOSITION FOR REDUCING NEW-ONSET DIABETES
#606Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
#607TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF
#608Compositions and methods for treating the eye
#609METHODS OF TREATING OR PREVENTING PROSTATE CANCER
#610GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#611ENGINEERED CELLS, AND METHODS OF USING THE SAME
#612Compositions and methods relating to salts of specialized pro-resolving mediators
#613METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT WITH ATRIAL FIBRILLATION AND/OR ATRIAL FLUTTER
#614OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS
#615Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
#616TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATMENT OF MALE SUBJECTS
#617SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID
#618Micro-emulsion containing creatine fatty-ester, method for preparing said micro-emulsion and uses thereof
#619GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION
#620OMEGA-3 FATTY ACID SUPPLEMENTATION FOR USE IN TREATING DRY EYE
#621Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
#622METFORMIN COMPOUNDED COMPOSITION AND METHOD THEREOF
#623COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION
#624Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
#625Stable pharmaceutical composition and methods of using same
#626METHODS OF TREATING MIXED DYSLIPIDEMIA
#627COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND MIPOMERSEN AND METHODS OF USE THEREOF
#628Use of H3K9me3 modulation for enhancing cognitive function
#629Free polyunsaturated fatty acid-containing composition and manufacturing method therefor
#630METHODS OF TREATING MIXED DYSLIPIDEMIA
#631METHODS OF TREATING MIXED DYSLIPIDEMIA
#632PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF
#633COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#634Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof
#635METHODS OF REDUCING OR PREVENTING OXIDATION OF SMALL DENSE LDL OR MEMBRANE POLYUNSATURATED FATTY ACIDS
#636COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING CANCER AND NEUROLOGIC DISEASE
#637METHODS OF TREATING DISEASES AND DISORDERS USING COMPOSITIONS COMPRISING 18-HEPE, 12-HEPE, OR COMBINATIONS THEREOF
#638Inhibition of mir-22 miRNA by APT-110
#639Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#640TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#641METHODS AND COMPOSITIONS OF TREATING PANCREATIC CANCER
#642Lymphatic circulation improving agents
#643PUFA SALT FORMULATIONS (II)
#644A METHOD INDUCING SATIETY IN A MAMMAL
#645Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
#646COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF
#647METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#648ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID
#649WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION
#650NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING MENTAL WELLNESS AND/OR MOOD
#651Materials and methods for increasing the tocopherol content in seed oil
#652Systems and methods for thrombosis prevention
#653Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
#654METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#655Combination methods and compositions including sleep therapeutics for treating mood
#656ANTI-INFECTIVE ANTIMICROBIAL-CONTAINING BIOMATERIALS
#657Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
#658MULTIPARTICULATE SOLID DOSAGE FORM HAVING AN ELASTIC TEXTURE
#659HYDROCARBON / LIPID - CAROTENOID COMPLEXES
#660Compositions and methods for treating the eye
#661FREEZE-DRIED MULTIPARTICULATE SOLID DOSAGE FORM
#662Methods of treating mixed dyslipidemia
#663Ophthalmic compositions
#664Stable pharmaceutical composition and methods of using same
#665Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof
#666PLANT-BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS
#667Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
#668Purified compositions of polyunsaturated fatty acids, their preparation method and their use
#669SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID
#670COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#671Nutraceutical formulation for unblocking receptors
#672THRAUSTOCHYTRIDS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
#673Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by
#674Methods and products to provide oral nutritional care to subjects with dementia
#675PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CHOLESTEROL GALLSTONE COMPRISING URSODEOXYCHOLIC ACID (UDCA) AND OMEGA-3 FATTY ACID, AND PROCESS FOR PRODUCING THE SAME
#676PLANT EXTRACTS FROM THE TAGETES GENUS AND USES OF SAME
#677Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids
#678Compositions and methods using a polyphenol for musculoskeletal health
#679Diabetes Control Using Postprandial Feedback
#680METHODS OF ASSESSING FUTURE MEMORY LOSS BY MEASURING POLYUNSATURATED FATTY ACIDS
#681COMPOSITIONS COMPRISING 15-HEPE AND/OR 15-HETrE AND METHODS OF TREATING OR PREVENTING CARDIOMETABOLIC DISEASE, METABOLIC SYNDROME, AND/OR RELATED DISEASES
#682Use of derivatives of polyunsaturated fatty acids as medicaments
#683Self-emulsifying composition of ω-3 fatty acid
#684Composition for preventing or improving nociceptive pain
#685Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
#686Compositions and methods of treating cancer using lipid agonists and receptors thereof
#687Formulations for Treating and/or Preventing Disease
#688Pharmaceutical compositions comprising DGLA and use of same
#689Nutritional composition for treating or preventing impaired mobility
#690Non-winterized, standardized marine source oil products and methods of making thereof
#691Compositions comprising Omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
#692Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
#693Method for preparing a composition comprising omega-3 fatty acid salts and amines
#694TOPICAL FORMULATION FOR INFLAMMATORY SKIN CONDITIONS
#695CURE FOR ALZHEIMER'S DISEASE
#696Composition comprising EPA and DHA for an enhanced efficacy of anticancer agents
#697Ingestible medical delivery devices
#698Stable pharmaceutical composition and methods of using same
#699LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY
#700COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#701Isotretinoin formulations and uses and methods thereof
#702Compositions comprising omega-3 polyunsaturated and medium chain fatty acids
#703SPIRULINA CAROTENOID COMPLEX
#704METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS
#705Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
#706Intestinal barrier integrity
#707Nutritional composition
#708Compositions and methods for the treatment of cancer
#709Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
#710PELLETED RUMINANT FEED ENRICHED WITH RUMEN-AVAILABLE INGREDIENTS
#711METHOD FOR TREATING TRAUMATIC BRAIN INJURY
#712Intelligent delivery of ingested and absorbed molecules
#713METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A STATIN-TREATED SUBJECT BY INCREASING SERUM AND PLASMA EPA AND DPA LEVELS
#714Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
#715PHARMACEUTICAL COMPOSITIONS
#716Semifluorinated alkane compositions
#717Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations
#718METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#719EMULSION AND EMULSION PRECONCENTRATE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND USES THEREOF
#720Methods and compositions for treatment of inflammatory bowel disease
#721METHODS OF REDUCING OR PREVENTING OXIDATION OF SMALL DENSE LDL OR MEMBRANE POLYUNSATURATED FATTY ACIDS
#722METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS
#723Emulsified oils and blends
#724Multi-nutrient composition
#725Flavonoid compositions and methods of use
#726NUTRITIONAL FORMULATIONS USING HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION
#727ALL-NATURAL TOPICAL PAIN RELIEF OINTMENT
#728Nutritional Composition With Human Milk Oligosaccharides And Uses Thereof
#729METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#730Esters for Treatment of Ocular Inflammatory Conditions
#731Compositions and methods that modulate bacteria in a companion animal
#732Methods of treating hypertriglyceridemia
#733Methods For Assessing Risk Of Cardiovascular Disease And Methods And Compounds For Use In Treating Or Preventing Cardiovascular Disease
#734Composition and uses thereof
#735Esters for treatment of ocular inflammatory conditions
#736A PERSONAL CARE COMPOSITION
#737Solid solution compositions and use in chronic inflammation
#738Protection of polyunsaturated fatty acids from ruminal degradation
#739Memory in subjects with mini-mental state examination of 24-26
#740TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
#741COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
#742COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
#743PHARMACEUTICALLY ACCEPTABLE SALTS OF FATTY ACIDS
#744Compositions and methods relating to salts of specialized pro-resolving mediators
#745Compositions and methods for treating depression
#746Composition and functional food for preventing myopia
#747Reduced fat, shelf stable liquid nutritional composition
#748Lipid compositions containing bioactive fatty acids
#749Maresins for use in the treatment of CNS injuries
#750Resolvin mimetic antibodies and uses thereof
#751Nutritional compositions and methods for promoting cognitive development
#752FREE POLYUNSATURATED FATTY ACID-CONTAINING COMPOSITION AND MANUFACTURING METHOD THEREFOR
#753Synbiotic composition for preventing disorders
#754Diagnosis of diabetes by detecting aggregated amylin in erythrocytes
#755FLAVONOID COMPOSITIONS AND METHODS OF USE
#756COMPOSITION FOR USE IN THE TREATMENT OF ENDOMETRIOSIS AND SYMPTOMS ASSOCIATED WITH ENDOMETRIOSIS
#757Methods for increasing oral osteogenesis using lipoxin A(LXA) and its analogs
#758Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease
#759Compositions comprising thymoquinone and omega-3 fatty acids
#760USE OF WITHANIA SOMNIFERA EXTRACT TO PROTECT AGAINST AIR POLLUTION RELATED DISEASES
#761Alleviating oxidative stress disorders with PUFA derivatives
#762COMPOSITIONS AND METHODS FOR WOUND CLOSURE
#763Method of glucose-dependent insulinotropic polypeptide (GIP) stabilization
#764DIRECT APPLICATION SYSTEM AND METHOD FOR THE DELIVERY OF BIOACTIVE COMPOSITIONS AND FORMULATIONS
#765Methods of treating mixed dyslipidemia
#766Transdermal optical detection of cardiac biomarkers
#767Stable pharmaceutical composition and methods of using same
#768Compounds and Methods for Modulating Vascular Injury
#769Emulsified fatty acids
#770Methods and compositions for treating diseases related to imbalance of essential fatty acids
#771Composition for external use on skin for inflammatory diseases
#772Composition for improving efficacy of L-DOPA treatment
#773Metabolism-improving agent comprising rare fatty acid
#774Sickle cell disease treatment utilizing omega-3 fatty acids
#775Omega-3 Fatty Acid Composition for Preventing and/or Treating Cachexia
#776PUFA salt formulations (I)
#777Pharmaceutical compositions comprising DGLA and use of same
#778Compositions comprising 15-HEPE and methods of using the same
#779Compositions and methods using a polyphenol for musculoskeletal health
#780Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients
#781Methods of treating hypertriglyceridemia
#782METHODS OF TREATING HYPERCHOLESTEROLEMIA
#783Compositions for mitigating brain trauma and methods thereof
#784Enzyme-assisted supercritical extraction of nigella sativa seeds
#785COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA
#786Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
#787METHODS FOR TREATING CANCER, AND COMPOSITIONS THEREFOR
#788Self-emulsifying composition of w3 fatty acid
#789Methods for decreasing injuries associated with intraoperative hypotension
#790Omega 3 fatty acids and choline as neuroprotectant in patients with no dementia
#791Specialized pro-resolving lipid mediators for use in the treatment of neurodegenerative diseases and/or autoimmune diseases
#792Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
#793CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF
#794Long-term efficacy of liver disease treatment with EPA and DHA
#795METHODS OF USE IN SUPPORT OF PLANNED SUPPLEMENT AND FOOD INGREDIENT PRODUCTS FOR DIAGNOSIS AND TREATMENT OF ANEMIA
#796NOVEL USES OF PCSK9 INHIBITORS AND RELATED MEDICATIONS
#797Compositions Containing Enriched Natural Crocin and/or Crocetin, and Their Therapeutic or Nutraceutical Uses
#798GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#799Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
#800COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SCHISTOSOMIASIS
#801FAD4, FAD5, FAD5-2, AND FAD6, NOVEL FATTY ACID DESATURASE FAMILY MEMBERS AND USES THEREOF
#802Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological
#803Stable pharmaceutical composition and methods of using same
#804METHODS FOR LOWERING TRIGLYCERIDE LEVELS WITH A CONCENTRATED FISH OIL-BASED PHARMACEUTICAL COMPOSITION
#805INTACT PEA PROTEIN-BASED NUTRIENT COMPOSITION
#806Cannabinoid-Containing Fatty Acid Formulations for Treating Disorders of the Nervous System
#807TREATMENT WITH HIGHLY PURIFIED EICOSAPENTAENOIC ACID AS FREE FATTY ACID IMPROVES INFLAMMATION, AFFECTS COLONIC DIFFERENTIATION MARKERS AND MICROBIOTA IN PATIENTS WITH ULCERATIVE COLITIS
#808Nutritional composition for use in therapy of cancer patients
#809Omega-3 compositions and methods relating thereto
#810NATURAL LIPIDS CONTAINING NON-OXIDIZABLE FATTY ACIDS
#811Highly purified eicosapentaenoic acid, as free fatty acid, reduces fecal calprotectin levels and prevents clinical relapse in ulcerative colitis patients
#812Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
#813POWDERS AND TABLETS COMPRISING OMEGA-3 FATTY ACID DERIVATIVES AND METHODS FOR THEIR PRODUCTION
#814Method of fabricating an electronic power module by additive manufacturing, and associated substrate and module
#815Compositions containing omega-3 oil and uses thereof
#816COMPOSITION FOR REDUCING NEW-ONSET DIABETES
#817Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
#818Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome
#819THERAPEUTIC MODULATION OF C-FOS IN THE EYE
#820Compositions and methods for the treatment of chronic pain
#821BIOMARKERS OF BLOOD-BRAIN BARRIER DYSFUNCTION
#822Compositions and Methods for Treating Neurologic Disorders
#823Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#824Esters for treatment of ocular inflammatory conditions
#825Fatty acid formulations and methods of use thereof
#826ORAL COMPOSITION WITH IMMUNOMODULATING EFFECT ON NATURAL KILLER CELLS
#827Compositions of coenzyme Q10 and methods of use
#828Prevention of psychotic disorders and/or treatment of psychotic symptoms
#829Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
#830Cancer-killing cells
#831Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
#832Treatment for non-alcoholic fatty liver diseases
#833Topical compositions comprising polyunsaturated fatty acids
#834Methods and Compositions for Rectal Administration of Exenatide
#835METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES
#836PREVENTION AND/OR TREATMENT OF NEURODEGENERATIVE DISEASE
#837Probiotic confection and lipid compositions
#838Nutritional composition for improving cell membranes
#839LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE
#840Isotopically modified components and therapeutic uses thereof
#841BIOCONJUGATE MOLECULES WITH BIOLOGICAL AND TECHNO-FUNCTIONAL ACTIVITY, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
#842Compositions and methods for lowering triglycerides
#843Pharmaceutical compositions comprising DGLA and use of same
#844ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
#845Nutritional compositions and infant formula for promoting de novo myealination
#846Use of TRPV4 antagonists to ameliorate hydrocephalus and related materials and methods
#847Materials and methods for increasing the tocopherol content in seed oil
#848Nutritional composition and infant formula for promoting myelination of the brain
#849Nutritional formula
#850Nutritional supplements containing a peptide component and uses thereof
#851COMPOSITIONS AND METHODS FOR LOWERING LEVELS OF HIGH-SENSITIVITY (HS-CRP) IN A SUBJECT
#852Methods of treating mixed dyslipidemia
#853MCT-BASED NUTRITION BLEND FOR PROVIDING HEALTH BENEFITS IN COMPANION ANIMALS
#854Neurodegenerative disorders and muscle diseases implicating PUFAs
#855SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID
#856TREATMENT OF A DISEASE MEDIATED BY ARACHIDONIC ACID OR AN EICOSANOID
#857DISORDERS IMPLICATING PUFA OXIDATION
#858Nutritional supplements containing a peptide component and uses thereof
#859Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by
#860Enteral feeding devices and related methods of use
#861COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME
#862METHODS OF INCREASING THE OMEGA-3 POLYUNSATURATED FATTY ACIDS LEVELS IN HUMAN PLASMA
#863VEGETARIAN COMPOSITION CONTAINING UNSATURATED FATTY ACIDS
#864COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME
#865Method and apparatus for the manufacture of softgels
#866Methods of treatment using a lipid extract of seeds concentrated in its unsaponifiable fraction
#867Omega 3 fatty acids, no releasing compound and vitamin B12 as neuroprotectant in patients with no dementia
#868Use of H3K9me3 modulation for enhancing cognitive function
#869Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
#870METHODS OF REDUCING OR PREVENTING OXIDATION OF LDL OR LIPID MEMBRANES IN A SUBJECT IN NEED THEREOF
#871Medicinal composition of extract of seed of emblica officinalis and method of preparing the same
#872Lysophosphatidylcholine compositions
#873PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME
#874Oils with anti-inflammatory activity containing natural Specialized Proresolving Mediators and their precursors
#875Compositions for Diagnosis and Treatment of Anemia
#876Lipid comprising docosapentaenoic acid
#877Compositions for the skin
#878Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
#879Method of using omega 3 fatty acids to treat diseases which involve damage to the nervous system
#880Method for increasing uridine concentration in blood plasma
#881COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF
#882METHODS OF TREATING PEDIATRIC METABOLIC SYNDROME
#883Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
#884Methods of treating mixed dyslipidemia
#885Omega-3 fatty acid articles of manufacture, and methods and apparatus for making same
#886Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
#887PRODUCTS CONTAINING HIGHLY UNSATURATED FATTY ACIDS FOR USE BY WOMEN AND THEIR CHILDREN DURING STAGES OF PRECONCEPTION, PREGNANCY AND LACTATION/POST-PARTUM
#888Method for controlling neuroinflammation
#889Compositions and method for treating and preventing malnutrition
#890COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
#891LOW ERUCTATION COMPOSITION AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE IN A SUBJECT WITH FISH ALLERGY/HYPERSENSITIVITY
#892Metal and Ceramic Nanofibers
#893Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
#894PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
#895Self-emulsifying composition of Ω3 fatty acid
#896Compositions containing PUFA and/or uridine and methods of use thereof
#897TRANSIENT PROTECTION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AGAINST IONIZING RADIATION
#898Prevention and/or treatment of neurodegenerative disease
#899SOFT GELATIN ENCAPSULATED PHARMACEUTICAL COMPOSITION OF CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID IN FREE ACID FORM AND CIS-7,10,13,16,19-DOCOSAPENTAENOIC ACID IN FREE ACID FORM
#900Hydroxyeicosatrienoic acid compounds and their use as therapeutic agents